In utero stem cell transplantation for inherited blood cell disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Flake, A.W. et al. Successful treatment of X-linked recessive severe combined immunodeficiency (X-SCID) by the in utero transplantation of CD34 enriched paternal bone marrow cells. Blood 86, 125a (1995).
Buckley, R.H. et al. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J. Immunoi. 136, 2398–2407 (1986).
Noguchi, M. et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147–157 (1993).
Cowan, M.J. and Globus, M. In utero hematopoietic stem cell transplants for inherited diseases. Am. J. Pediat. Hematol. J. Oncol. 16, 35–42 (1994).
Nesci, S. et al. Mixed chimerism in thalassemic patients after bone marrow transplantation. B.M.T. 10, 143–146 (1992).
Kapelushnik, J. et al. Analysis of β-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation. Blood 86, 3241–3246 (1995).
Lucarelli, G. et al. Marrow transplantation in patients with thalassemia responsive to chelation therapy N. Engl. J. Med. 329, 840–844 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blau, C., Stamatoyannopoulos, G. Preemptive therapy for genetic disease. Nat Med 2, 161–162 (1996). https://doi.org/10.1038/nm0296-161
Issue Date:
DOI: https://doi.org/10.1038/nm0296-161
This article is cited by
-
Möglichkeiten der intrauterinen Therapie bei Risikograviditäten
Reproduktionsmedizin (2002)